Effect of non finasteride combined with M receptor antagonists in the treatment of benign prostatic hyperplasia with overactive bladder

Objective To investigate and analyze the hyperplasia of prostate and bladder hyperactive disorder take finasteride combined the clinical curative effect and value of M receptor antagonist treatment. Methods from January 2012 to June 2012 treated 70 cases of hyperplasia of prostate and bladder hyperactive disorder patients as the research object, all give finasteride combined M receptor antagonist treatment, observation and comparison before and after treatment in patients with IPSS(international prostate symptom score), OABSS bladder hyperactive disorder(score) and urgency number changes. Results After treatment, the patients of IPSS score, OABSS score was significantly decreased, the number of urgency, residual urine volume, prostate volume was significantly reduced the; Each index contrast differences before and after the treatment are statistically significant. Conclusion Clinical patients with hyperplasia of prostate and bladder hyperactive disorder give finasteride combined M receptor antagonist treatment, can significantly improve symptoms of prostate patients, alleviate bladder excessive activity, improve the function of patients with prostate cancer and improve the quality of life.